Change in Diabetic Retinopathy Through 2 Years Secondary Analysis of a Randomized Clinical Trial Comparing Aflibercept, Bevacizumab, and Ranibizumab

导出原文传递

翻译打印收藏纠错

作者： Bressler, Susan B. ^[1] ; Liu, Danni ^[2] ; Glassman, Adam R. ^[3] ; Blodi, Barbara A. ^[4] ; Castellarin, Alessandro A. ^[5] ; Jampol, Lee M. ^[6] ; Kaufman, Paul L. ^[7] ; Melia, Michele ^[8] ; Singh, Harinderjit ; Wells, John A.

作者单位： Jaeb Ctr Hlth Res, Tampa, FL USA ^[1] Univ Wisconsin, Fundus Photograph Reading Ctr, Madison, WI USA ^[2] Calif Retina Consultants & Res Fdn, Santa Barbara, CA USA ^[3] Thomas Eye Grp, Atlanta, GA USA ^[4] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA ^[5] Palmetto Retina Ctr, Columbia, SC USA ^[6] Southeast Retina Ctr, PC, Augusta, GA USA ^[7] Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD 21205 USA ^[8]

发布时间 2017-12-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

JAMA ophthalmology

2017年135卷6期

558-568页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Change in Diabetic Retinopathy Through 2 Years Secondary Analysis of a Randomized Clinical Trial Comparing Aflibercept, Bevacizumab, and Ranibizumab

JAMA ophthalmology

相似文献

JAMA ophthalmology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Change in Diabetic Retinopathy Through 2 Years Secondary Analysis of a Randomized Clinical Trial Comparing Aflibercept, Bevacizumab, and Ranibizumab

JAMA ophthalmology

相似文献

JAMA ophthalmology

相关期刊

检索历史清除